BioCentury
ARTICLE | Company News

Biolipox, Orexo deal

October 22, 2007 7:00 AM UTC

ORX will acquire Biolipox for 8.6 million shares valued at SEK776.8 million ($120.9 million) based on ORX's close of SEK90.75 on Oct. 12, the last trading day before the deal was announced. Biolipox shareholders would own 38% of the combined company, and Biolipox CEO Torbjorn Bjerke would be CEO. ORX CEO Zsolt Lavotha would depart. The deal is expected to close in November. ...